Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1245247

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1245247

Europe Cardiovascular Digital Solutions Market Size, Share & Industry Trends Analysis Report By Service Type, By End-use, By Deployment (Cloud-Based and On-premise), By Components (Devices and Software), By Country and Growth Forecast, 2022 - 2028

PUBLISHED:
PAGES: 100 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Site License)
USD 1800
PDF (Enterprisewide License)
USD 2520

Add to Cart

The Europe Cardiovascular Digital Solutions Market would witness market growth of 4.1% CAGR during the forecast period (2022-2028).

Digital solutions are frequently used in healthcare to track the spread of infectious illnesses, monitor the quality of patient care, and evaluate clinical support. Utilizing cardiovascular digital solutions improves patient care through improved health monitoring, more individualized patient care, and decreased inefficiencies. The future of healthcare technology is bright because of digital innovations like wearable technology, telemedicine, and virtual reality technologies.

An example of a wearable gadget that could be utilized to assist in the management of CVD is a fitness tracker. Additionally, a home-based wearable constant ECG monitoring patch was successfully used by the mSToPS RCT to identify individuals with atrial fibrillation. The Apple Heart Study showed that the Apple Watch is only moderately good at detecting atrial fibrillation in its users. The EXPERT stands for Exercise Prescription in Everyday Practice & Rehabilitation Training. This tool illustrates a clinical electronic decision support tool.

EXPERT was developed by the European Association for Preventive Cardiology (EAPC) as an interactive decision tool that enables medical professionals to use an algorithm to compare their exercise recommendations to specified patient instances. Similarly, a customized EHR-based warning system could enhance the use of medication for heart failure that is prescribed according to guidelines, as demonstrated by the recent PROMPT-HF trial. The automatic interpretation of medical imaging data can also be helped by artificial intelligence decision-support tools.

Pharmaceutical companies are also engaged in the development of effective medications to address the rise in cardiac problems. The European Medicines Agency has prepared a complete overview of the current guidelines and possibilities for participation during the development phase of a medicinal product (EMA). The agency aims to provide scientific and regulatory assistance for the development of application materials as well as a smooth validation and assessment procedure. Other nations, like the UK, Germany, and Denmark, where regulatory authorities have developed legislation relating to digital pharmaceuticals and digital health solutions, have seen a similar rise. In addition, the requirement for digital solutions is predicted to expand, given the present activity in this region and the rising need for such solutions.

The Germany market dominated the Europe Cardiovascular Digital Solutions Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $8,345.3 Million by 2028. The UK market is estimated to grow a CAGR of 3.3% during (2022 - 2028). Additionally, The France market would experience a CAGR of 4.9% during (2022 - 2028).

Based on Service Type, the market is segmented into Unobtrusive Testing, CVD Health Informatics, Cardiac Rehab Programs and Others. Based on End-use, the market is segmented into Hospitals & Clinics, Ambulatory Care Centers and Others. Based on Deployment, the market is segmented into Cloud-Based and On-premise. Based on Components, the market is segmented into Devices and Software. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Apple, Inc., General Electric Company, Koninklijke Philips N.V., Verily Life Sciences LLC (Alphabet, Inc.), iRhythm Technologies, Inc., Bardy Diagnostics, Inc.(Hill-Rom Holdings Inc)(Baxter International Inc.), eviCore Healthcare (Express Scripts Holding Company) (Cigna Corporation), AliveCor, Inc., Cardiotrack, and HeartFlow, Inc.

Scope of the Study

Market Segments covered in the Report:

By Service Type

  • Unobtrusive Testing
  • CVD Health Informatics
  • Cardiac Rehab Programs
  • Others

By End-use

  • Hospitals & Clinics
  • Ambulatory Care Centers
  • Others

By Deployment

  • Cloud-Based
  • On-premise

By Components

  • Devices
  • Software

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Companies Profiled

  • Apple, Inc.
  • General Electric Company
  • Koninklijke Philips N.V.
  • Verily Life Sciences LLC (Alphabet, Inc.)
  • iRhythm Technologies, Inc.
  • Bardy Diagnostics, Inc.(Hill-Rom Holdings Inc)(Baxter International Inc.)
  • eviCore Healthcare (Express Scripts Holding Company) (Cigna Corporation)
  • AliveCor, Inc.
  • Cardiotrack
  • HeartFlow, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Europe Cardiovascular Digital Solutions Market, by Service Type
    • 1.4.2 Europe Cardiovascular Digital Solutions Market, by End-use
    • 1.4.3 Europe Cardiovascular Digital Solutions Market, by Deployment
    • 1.4.4 Europe Cardiovascular Digital Solutions Market, by Components
    • 1.4.5 Europe Cardiovascular Digital Solutions Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition & Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global

  • 3.1 KBV Cardinal Matrix
  • 3.2 Recent Industry Wide Strategic Developments
    • 3.2.1 Partnerships, Collaborations and Agreements
    • 3.2.2 Product Launches and Product Expansions
    • 3.2.3 Acquisition and Mergers
  • 3.3 Top Winning Strategies
    • 3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
    • 3.3.2 Key Strategic Move: (Product Launches and Product Expansions : 2018, Aug - 2022, Nov) Leading Players

Chapter 4. Europe Cardiovascular Digital Solutions Market by Service Type

  • 4.1 Europe Unobtrusive Testing Market by Country
  • 4.2 Europe CVD Health Informatics Market by Country
  • 4.3 Europe Cardiac Rehab Programs Market by Country
  • 4.4 Europe Others Market by Country

Chapter 5. Europe Cardiovascular Digital Solutions Market by End-use

  • 5.1 Europe Hospitals & Clinics Market by Country
  • 5.2 Europe Ambulatory Care Centers Market by Country
  • 5.3 Europe Others Market by Country

Chapter 6. Europe Cardiovascular Digital Solutions Market by Deployment

  • 6.1 Europe Cloud-Based Market by Country
  • 6.2 Europe On-premise Market by Country

Chapter 7. Europe Cardiovascular Digital Solutions Market by Components

  • 7.1 Europe Devices Market by Country
  • 7.2 Europe Software Market by Country

Chapter 8. Europe Cardiovascular Digital Solutions Market by Country

  • 8.1 Germany Cardiovascular Digital Solutions Market
    • 8.1.1 Germany Cardiovascular Digital Solutions Market by Service Type
    • 8.1.2 Germany Cardiovascular Digital Solutions Market by End-use
    • 8.1.3 Germany Cardiovascular Digital Solutions Market by Deployment
    • 8.1.4 Germany Cardiovascular Digital Solutions Market by Components
  • 8.2 UK Cardiovascular Digital Solutions Market
    • 8.2.1 UK Cardiovascular Digital Solutions Market by Service Type
    • 8.2.2 UK Cardiovascular Digital Solutions Market by End-use
    • 8.2.3 UK Cardiovascular Digital Solutions Market by Deployment
    • 8.2.4 UK Cardiovascular Digital Solutions Market by Components
  • 8.3 France Cardiovascular Digital Solutions Market
    • 8.3.1 France Cardiovascular Digital Solutions Market by Service Type
    • 8.3.2 France Cardiovascular Digital Solutions Market by End-use
    • 8.3.3 France Cardiovascular Digital Solutions Market by Deployment
    • 8.3.4 France Cardiovascular Digital Solutions Market by Components
  • 8.4 Russia Cardiovascular Digital Solutions Market
    • 8.4.1 Russia Cardiovascular Digital Solutions Market by Service Type
    • 8.4.2 Russia Cardiovascular Digital Solutions Market by End-use
    • 8.4.3 Russia Cardiovascular Digital Solutions Market by Deployment
    • 8.4.4 Russia Cardiovascular Digital Solutions Market by Components
  • 8.5 Spain Cardiovascular Digital Solutions Market
    • 8.5.1 Spain Cardiovascular Digital Solutions Market by Service Type
    • 8.5.2 Spain Cardiovascular Digital Solutions Market by End-use
    • 8.5.3 Spain Cardiovascular Digital Solutions Market by Deployment
    • 8.5.4 Spain Cardiovascular Digital Solutions Market by Components
  • 8.6 Italy Cardiovascular Digital Solutions Market
    • 8.6.1 Italy Cardiovascular Digital Solutions Market by Service Type
    • 8.6.2 Italy Cardiovascular Digital Solutions Market by End-use
    • 8.6.3 Italy Cardiovascular Digital Solutions Market by Deployment
    • 8.6.4 Italy Cardiovascular Digital Solutions Market by Components
  • 8.7 Rest of Europe Cardiovascular Digital Solutions Market
    • 8.7.1 Rest of Europe Cardiovascular Digital Solutions Market by Service Type
    • 8.7.2 Rest of Europe Cardiovascular Digital Solutions Market by End-use
    • 8.7.3 Rest of Europe Cardiovascular Digital Solutions Market by Deployment
    • 8.7.4 Rest of Europe Cardiovascular Digital Solutions Market by Components

Chapter 9. Company Profiles

  • 9.1 Apple, Inc.
    • 9.1.1 Company Overview
    • 9.1.2 Financial Analysis
    • 9.1.3 Regional Analysis
    • 9.1.4 Research & Development Expense
    • 9.1.5 SWOT Analysis
  • 9.2 General Electric Company
    • 9.2.1 Company Overview
    • 9.2.2 Financial Analysis
    • 9.2.3 Segmental and Regional Analysis
    • 9.2.4 Research & Development Expense
    • 9.2.5 Recent strategies and developments:
      • 9.2.5.1 Partnerships, Collaborations, and Agreements:
      • 9.2.5.2 Product Launches and Product Expansions:
      • 9.2.5.3 Acquisition and Mergers:
  • 9.3 Koninklijke Philips N.V.
    • 9.3.1 Company Overview
    • 9.3.2 Financial Analysis
    • 9.3.3 Segmental and Regional Analysis
    • 9.3.4 Research & Development Expense
    • 9.3.5 Recent strategies and developments:
      • 9.3.5.1 Partnerships, Collaborations, and Agreements:
      • 9.3.5.2 Product Launches and Product Expansions:
      • 9.3.5.3 Acquisition and Mergers:
  • 9.4 Verily Life Sciences LLC (Alphabet, Inc.)
    • 9.4.1 Company Overview
    • 9.4.2 Financial Analysis
    • 9.4.3 Segmental and Regional Analysis
    • 9.4.4 Research & Development Expense
    • 9.4.5 Recent strategies and developments:
      • 9.4.5.1 Product Launches and Product Expansions:
  • 9.5 iRhythm Technologies, Inc.
    • 9.5.1 Company Overview
    • 9.5.2 Financial Analysis
    • 9.5.3 Research & Development Expense
  • 9.6 Bardy Diagnostics, Inc.(Hill-Rom Holdings Inc)(Baxter International Inc.)
    • 9.6.1 Company Overview
    • 9.6.2 Financial Analysis
    • 9.6.3 Segmental Analysis
    • 9.6.4 Research & Development Expense
    • 9.6.5 Recent strategies and developments:
      • 9.6.5.1 Product Launches and Product Expansions:
  • 9.7 eviCore Healthcare (Express Scripts Holding Company) (Cigna Corporation)
    • 9.7.1 Company Overview
    • 9.7.2 Financial Analysis
    • 9.7.3 Segmental Analysis
  • 9.8 AliveCor, Inc.
    • 9.8.1 Company Overview
    • 9.8.2 Recent strategies and developments:
      • 9.8.2.1 Partnerships, Collaborations, and Agreements:
      • 9.8.2.2 Product Launches and Product Expansions:
  • 9.9 Cardiotrack
    • 9.9.1 Company Overview
  • 9.10. HeartFlow, Inc.
    • 9.10.1 Company Overview

LIST OF TABLES

  • TABLE 1 Europe Cardiovascular Digital Solutions Market, 2018 - 2021, USD Million
  • TABLE 2 Europe Cardiovascular Digital Solutions Market, 2022 - 2028, USD Million
  • TABLE 3 Partnerships, Collaborations and Agreements- Cardiovascular Digital Solutions Market
  • TABLE 4 Product Launches And Product Expansions- Cardiovascular Digital Solutions Market
  • TABLE 5 Acquisition and Mergers- Cardiovascular Digital Solutions Market
  • TABLE 6 Europe Cardiovascular Digital Solutions Market by Service Type, 2018 - 2021, USD Million
  • TABLE 7 Europe Cardiovascular Digital Solutions Market by Service Type, 2022 - 2028, USD Million
  • TABLE 8 Europe Unobtrusive Testing Market by Country, 2018 - 2021, USD Million
  • TABLE 9 Europe Unobtrusive Testing Market by Country, 2022 - 2028, USD Million
  • TABLE 10 Europe CVD Health Informatics Market by Country, 2018 - 2021, USD Million
  • TABLE 11 Europe CVD Health Informatics Market by Country, 2022 - 2028, USD Million
  • TABLE 12 Europe Cardiac Rehab Programs Market by Country, 2018 - 2021, USD Million
  • TABLE 13 Europe Cardiac Rehab Programs Market by Country, 2022 - 2028, USD Million
  • TABLE 14 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 15 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 16 Europe Cardiovascular Digital Solutions Market by End-use, 2018 - 2021, USD Million
  • TABLE 17 Europe Cardiovascular Digital Solutions Market by End-use, 2022 - 2028, USD Million
  • TABLE 18 Europe Hospitals & Clinics Market by Country, 2018 - 2021, USD Million
  • TABLE 19 Europe Hospitals & Clinics Market by Country, 2022 - 2028, USD Million
  • TABLE 20 Europe Ambulatory Care Centers Market by Country, 2018 - 2021, USD Million
  • TABLE 21 Europe Ambulatory Care Centers Market by Country, 2022 - 2028, USD Million
  • TABLE 22 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 23 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 24 Europe Cardiovascular Digital Solutions Market by Deployment, 2018 - 2021, USD Million
  • TABLE 25 Europe Cardiovascular Digital Solutions Market by Deployment, 2022 - 2028, USD Million
  • TABLE 26 Europe Cloud-Based Market by Country, 2018 - 2021, USD Million
  • TABLE 27 Europe Cloud-Based Market by Country, 2022 - 2028, USD Million
  • TABLE 28 Europe On-premise Market by Country, 2018 - 2021, USD Million
  • TABLE 29 Europe On-premise Market by Country, 2022 - 2028, USD Million
  • TABLE 30 Europe Cardiovascular Digital Solutions Market by Components, 2018 - 2021, USD Million
  • TABLE 31 Europe Cardiovascular Digital Solutions Market by Components, 2022 - 2028, USD Million
  • TABLE 32 Europe Devices Market by Country, 2018 - 2021, USD Million
  • TABLE 33 Europe Devices Market by Country, 2022 - 2028, USD Million
  • TABLE 34 Europe Software Market by Country, 2018 - 2021, USD Million
  • TABLE 35 Europe Software Market by Country, 2022 - 2028, USD Million
  • TABLE 36 Europe Cardiovascular Digital Solutions Market by Country, 2018 - 2021, USD Million
  • TABLE 37 Europe Cardiovascular Digital Solutions Market by Country, 2022 - 2028, USD Million
  • TABLE 38 Germany Cardiovascular Digital Solutions Market, 2018 - 2021, USD Million
  • TABLE 39 Germany Cardiovascular Digital Solutions Market, 2022 - 2028, USD Million
  • TABLE 40 Germany Cardiovascular Digital Solutions Market by Service Type, 2018 - 2021, USD Million
  • TABLE 41 Germany Cardiovascular Digital Solutions Market by Service Type, 2022 - 2028, USD Million
  • TABLE 42 Germany Cardiovascular Digital Solutions Market by End-use, 2018 - 2021, USD Million
  • TABLE 43 Germany Cardiovascular Digital Solutions Market by End-use, 2022 - 2028, USD Million
  • TABLE 44 Germany Cardiovascular Digital Solutions Market by Deployment, 2018 - 2021, USD Million
  • TABLE 45 Germany Cardiovascular Digital Solutions Market by Deployment, 2022 - 2028, USD Million
  • TABLE 46 Germany Cardiovascular Digital Solutions Market by Components, 2018 - 2021, USD Million
  • TABLE 47 Germany Cardiovascular Digital Solutions Market by Components, 2022 - 2028, USD Million
  • TABLE 48 UK Cardiovascular Digital Solutions Market, 2018 - 2021, USD Million
  • TABLE 49 UK Cardiovascular Digital Solutions Market, 2022 - 2028, USD Million
  • TABLE 50 UK Cardiovascular Digital Solutions Market by Service Type, 2018 - 2021, USD Million
  • TABLE 51 UK Cardiovascular Digital Solutions Market by Service Type, 2022 - 2028, USD Million
  • TABLE 52 UK Cardiovascular Digital Solutions Market by End-use, 2018 - 2021, USD Million
  • TABLE 53 UK Cardiovascular Digital Solutions Market by End-use, 2022 - 2028, USD Million
  • TABLE 54 UK Cardiovascular Digital Solutions Market by Deployment, 2018 - 2021, USD Million
  • TABLE 55 UK Cardiovascular Digital Solutions Market by Deployment, 2022 - 2028, USD Million
  • TABLE 56 UK Cardiovascular Digital Solutions Market by Components, 2018 - 2021, USD Million
  • TABLE 57 UK Cardiovascular Digital Solutions Market by Components, 2022 - 2028, USD Million
  • TABLE 58 France Cardiovascular Digital Solutions Market, 2018 - 2021, USD Million
  • TABLE 59 France Cardiovascular Digital Solutions Market, 2022 - 2028, USD Million
  • TABLE 60 France Cardiovascular Digital Solutions Market by Service Type, 2018 - 2021, USD Million
  • TABLE 61 France Cardiovascular Digital Solutions Market by Service Type, 2022 - 2028, USD Million
  • TABLE 62 France Cardiovascular Digital Solutions Market by End-use, 2018 - 2021, USD Million
  • TABLE 63 France Cardiovascular Digital Solutions Market by End-use, 2022 - 2028, USD Million
  • TABLE 64 France Cardiovascular Digital Solutions Market by Deployment, 2018 - 2021, USD Million
  • TABLE 65 France Cardiovascular Digital Solutions Market by Deployment, 2022 - 2028, USD Million
  • TABLE 66 France Cardiovascular Digital Solutions Market by Components, 2018 - 2021, USD Million
  • TABLE 67 France Cardiovascular Digital Solutions Market by Components, 2022 - 2028, USD Million
  • TABLE 68 Russia Cardiovascular Digital Solutions Market, 2018 - 2021, USD Million
  • TABLE 69 Russia Cardiovascular Digital Solutions Market, 2022 - 2028, USD Million
  • TABLE 70 Russia Cardiovascular Digital Solutions Market by Service Type, 2018 - 2021, USD Million
  • TABLE 71 Russia Cardiovascular Digital Solutions Market by Service Type, 2022 - 2028, USD Million
  • TABLE 72 Russia Cardiovascular Digital Solutions Market by End-use, 2018 - 2021, USD Million
  • TABLE 73 Russia Cardiovascular Digital Solutions Market by End-use, 2022 - 2028, USD Million
  • TABLE 74 Russia Cardiovascular Digital Solutions Market by Deployment, 2018 - 2021, USD Million
  • TABLE 75 Russia Cardiovascular Digital Solutions Market by Deployment, 2022 - 2028, USD Million
  • TABLE 76 Russia Cardiovascular Digital Solutions Market by Components, 2018 - 2021, USD Million
  • TABLE 77 Russia Cardiovascular Digital Solutions Market by Components, 2022 - 2028, USD Million
  • TABLE 78 Spain Cardiovascular Digital Solutions Market, 2018 - 2021, USD Million
  • TABLE 79 Spain Cardiovascular Digital Solutions Market, 2022 - 2028, USD Million
  • TABLE 80 Spain Cardiovascular Digital Solutions Market by Service Type, 2018 - 2021, USD Million
  • TABLE 81 Spain Cardiovascular Digital Solutions Market by Service Type, 2022 - 2028, USD Million
  • TABLE 82 Spain Cardiovascular Digital Solutions Market by End-use, 2018 - 2021, USD Million
  • TABLE 83 Spain Cardiovascular Digital Solutions Market by End-use, 2022 - 2028, USD Million
  • TABLE 84 Spain Cardiovascular Digital Solutions Market by Deployment, 2018 - 2021, USD Million
  • TABLE 85 Spain Cardiovascular Digital Solutions Market by Deployment, 2022 - 2028, USD Million
  • TABLE 86 Spain Cardiovascular Digital Solutions Market by Components, 2018 - 2021, USD Million
  • TABLE 87 Spain Cardiovascular Digital Solutions Market by Components, 2022 - 2028, USD Million
  • TABLE 88 Italy Cardiovascular Digital Solutions Market, 2018 - 2021, USD Million
  • TABLE 89 Italy Cardiovascular Digital Solutions Market, 2022 - 2028, USD Million
  • TABLE 90 Italy Cardiovascular Digital Solutions Market by Service Type, 2018 - 2021, USD Million
  • TABLE 91 Italy Cardiovascular Digital Solutions Market by Service Type, 2022 - 2028, USD Million
  • TABLE 92 Italy Cardiovascular Digital Solutions Market by End-use, 2018 - 2021, USD Million
  • TABLE 93 Italy Cardiovascular Digital Solutions Market by End-use, 2022 - 2028, USD Million
  • TABLE 94 Italy Cardiovascular Digital Solutions Market by Deployment, 2018 - 2021, USD Million
  • TABLE 95 Italy Cardiovascular Digital Solutions Market by Deployment, 2022 - 2028, USD Million
  • TABLE 96 Italy Cardiovascular Digital Solutions Market by Components, 2018 - 2021, USD Million
  • TABLE 97 Italy Cardiovascular Digital Solutions Market by Components, 2022 - 2028, USD Million
  • TABLE 98 Rest of Europe Cardiovascular Digital Solutions Market, 2018 - 2021, USD Million
  • TABLE 99 Rest of Europe Cardiovascular Digital Solutions Market, 2022 - 2028, USD Million
  • TABLE 100 Rest of Europe Cardiovascular Digital Solutions Market by Service Type, 2018 - 2021, USD Million
  • TABLE 101 Rest of Europe Cardiovascular Digital Solutions Market by Service Type, 2022 - 2028, USD Million
  • TABLE 102 Rest of Europe Cardiovascular Digital Solutions Market by End-use, 2018 - 2021, USD Million
  • TABLE 103 Rest of Europe Cardiovascular Digital Solutions Market by End-use, 2022 - 2028, USD Million
  • TABLE 104 Rest of Europe Cardiovascular Digital Solutions Market by Deployment, 2018 - 2021, USD Million
  • TABLE 105 Rest of Europe Cardiovascular Digital Solutions Market by Deployment, 2022 - 2028, USD Million
  • TABLE 106 Rest of Europe Cardiovascular Digital Solutions Market by Components, 2018 - 2021, USD Million
  • TABLE 107 Rest of Europe Cardiovascular Digital Solutions Market by Components, 2022 - 2028, USD Million
  • TABLE 108 Key Information - Apple, Inc.
  • TABLE 109 KEY INFORMATION - GENERAL ELECTRIC Company
  • TABLE 110 Key Information - Koninklijke Philips N.V.
  • TABLE 111 Key Information - Verily Life Sciences LLC
  • TABLE 112 key information - iRhythm Technologies, Inc.
  • TABLE 113 Key Information - Bardy Diagnostics, Inc
  • TABLE 114 Key Information - eviCore Healthcare
  • TABLE 115 Key Information - AliveCor, Inc.
  • TABLE 116 Key Information - Cardiotrack
  • TABLE 117 Key Information - HeartFlow, Inc.

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 KBV Cardinal Matrix
  • FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
  • FIG 4 Key Strategic Move: (Product Launches and Product Expansions : 2018, aug - 2022, nov) Leading Players
  • FIG 5 SWOT Analysis: apple, Inc.
  • FIG 6 Recent strategies and developments: General Electric Company
  • FIG 7 Recent strategies and developments: Koninklijke Philips N.V.
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!